1,2-dipalmitoyl-3-phosphatidylethanolamine has been researched along with Metastase in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cossu, F; Melis, G; Rombi, G | 1 |
Warrington, RC | 1 |
1 review(s) available for 1,2-dipalmitoyl-3-phosphatidylethanolamine and Metastase
Article | Year |
---|---|
L-histidinol in experimental cancer chemotherapy: improving the selectivity and efficacy of anticancer drugs, eliminating metastatic disease and reversing the multidrug-resistant phenotype.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Drug Resistance; Histamine Antagonists; Histidine-tRNA Ligase; Histidinol; Membrane Glycoproteins; Mice; Neoplasm Metastasis; Neoplasm Proteins; Phosphatidylethanolamines; Tumor Cells, Cultured | 1992 |
1 other study(ies) available for 1,2-dipalmitoyl-3-phosphatidylethanolamine and Metastase
Article | Year |
---|---|
mAb-labeled liposomes in breast cancer cell targeting. Therapeutics and diagnostic use of polyspecific artificial carriers.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antibodies, Monoclonal; Brain Neoplasms; Breast Neoplasms; Drug Carriers; Female; Humans; Iodine Radioisotopes; Liposomes; Liver Neoplasms; Neoplasm Metastasis; Phosphatidylethanolamines; Radioimmunodetection; Technetium | 1993 |